Identification of Regulators of Polyploidization Presents Therapeutic Targets for Treatment of AMKL
暂无分享,去创建一个
Anne E Carpenter | Ling-Zhi Wang | Stuart L. Schreiber | Anne E. Carpenter | Mark-Anthony Bray | D. Gary Gilliland | James E. Bradner | Qiang Wen | Paul A. Clemons | Steven A. Carr | Lynn VerPlank | W. Frank An | Shai Izraeli | David E. Root | P. Clemons | S. Carr | S. Schreiber | D. Root | J. Bradner | S. Silver | M. Bray | V. Dancík | M. Schenone | B. Goh | W. Woods | N. Tolliday | T. Lewis | D. Gilliland | S. Izraeli | Q. Wen | J. Taub | Zan Huang | F. Pflumio | A. Stern | L. Verplank | Sasidhar Vemula | R. Kapur | T. Mercher | C. Lopez | J. Crispino | C. Thiollier | P. Ballerini | Benjamin H Goldenson | Serena J. Silver | Benjamin Goldenson | Laure Gilles | Vlado Dancik | F. Smith | Rama K. Mishra | Y. Birger | L. Goldberg | Thomas Mercher | Clarisse Thiollier | Boon-Cher Goh | Paola Ballerini | Lingzhi Wang | Monica Schenone | Zan Huang | Timothy A. Lewis | Xiaoyu Li | Lauren Diebold | Martha S. Vokes | Christopher B. Moore | Meghan Bliss-Moreau | Nicola J. Tolliday | Rama Mishra | Sasidhar Vemula | Jianjian Shi | Lei Wei | Reuben Kapur | Cécile K. Lopez | Bastien Gerby | Francoise Pflumio | Liat Goldberg | Yehudit Birger | Alan S. Gamis | Franklin O. Smith | William G. Woods | Jeffrey Taub | Christina A. Scherer | Robert J. Gould | Andrew M. Stern | John D. Crispino | A. Gamis | Jianjian Shi | Lei Wei | L. Gilles | Lauren P. Diebold | Robert Gould | W. F. An | B. Gerby | Christina A Scherer | Meghan Bliss-Moreau | C. B. Moore | Xiaoyu Li | Lynn Verplank | Bastien Gerby
[1] Rachel E. Gershman,et al. Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays , 2011, Clinical Cancer Research.
[2] Q. Wen,et al. Normal and malignant megakaryopoiesis , 2011, Expert Reviews in Molecular Medicine.
[3] T. Lewis,et al. Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL. , 2011, Cancer cell.
[4] Gary D. Smith,et al. Aurora kinase‐A regulates microtubule organizing center (MTOC) localization, chromosome dynamics, and histone‐H3 phosphorylation in mouse oocytes , 2011, Molecular reproduction and development.
[5] W. Vainchenker,et al. Aurora B is dispensable for megakaryocyte polyploidization, but contributes to the endomitotic process. , 2010, Blood.
[6] Peter J Houghton,et al. Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP) , 2010, Pediatric blood & cancer.
[7] Clive S Mason,et al. Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237. , 2010, ACS chemical biology.
[8] M. Saif,et al. Aurora kinase inhibitors as anti-cancer therapy , 2010, Anti-cancer drugs.
[9] Sasidhar Vemula,et al. ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability. , 2009, Blood.
[10] Jeffrey Ecsedy,et al. A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma. , 2009, Blood.
[11] D. Bluteau,et al. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. , 2009, Blood.
[12] T. Golub,et al. Empirical Bayes Analysis of Quantitative Proteomics Experiments , 2009, PloS one.
[13] J. Licht,et al. Survivin is not required for the endomitotic cell cycle of megakaryocytes. , 2009, Blood.
[14] D. Bluteau,et al. Regulation of megakaryocyte maturation and platelet formation , 2009, Journal of thrombosis and haemostasis : JTH.
[15] Sandra A. Moore,et al. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. , 2009, The Journal of clinical investigation.
[16] Steven A Carr,et al. Identifying the proteins to which small-molecule probes and drugs bind in cells , 2009, Proceedings of the National Academy of Sciences.
[17] S. Izraeli,et al. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. , 2009, Blood.
[18] T. Magnuson,et al. Aurora-A Kinase Is Essential for Bipolar Spindle Formation and Early Development , 2008, Molecular and Cellular Biology.
[19] B. Doble,et al. Prevention of Amino Acid Conversion in SILAC Experiments with Embryonic Stem Cells * , 2008, Molecular & Cellular Proteomics.
[20] R. Cortese,et al. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells , 2008, Molecular Cancer Therapeutics.
[21] N. Prévost,et al. Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout. , 2008, Blood.
[22] M. Weiss,et al. STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice. , 2007, The Journal of clinical investigation.
[23] G. Terstappen,et al. Target deconvolution strategies in drug discovery , 2007, Nature Reviews Drug Discovery.
[24] Rajesh Odedra,et al. AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis , 2007, Clinical Cancer Research.
[25] G. Blobel,et al. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. , 2007, Blood.
[26] N. Keen,et al. Discovery, synthesis, and in vivo activity of a new class of pyrazoloquinazolines as selective inhibitors of aurora B kinase. , 2007, Journal of medicinal chemistry.
[27] Gopal R. Gopinath,et al. Reactome: a knowledge base of biologic pathways and processes , 2007, Genome Biology.
[28] M. Mann,et al. A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.
[29] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[30] J. Drachman,et al. Increased megakaryocytopoiesis in Lyn-deficient mice , 2006, Oncogene.
[31] M. Weiss,et al. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1. , 2005, Blood.
[32] S. Orkin,et al. Developmental stage–selective effect of somatically mutated leukemogenic transcription factor GATA1 , 2005, Nature Genetics.
[33] Joël R. Pradines,et al. Analyzing Protein Lists with Large Networks: Edge-Count Probabilities in Random Graphs with Given Expected Degrees , 2005, J. Comput. Biol..
[34] L. Wodicka,et al. A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.
[35] J. Reems,et al. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. , 2004, Blood.
[36] W. Earnshaw,et al. The cellular geography of Aurora kinases , 2003, Nature Reviews Molecular Cell Biology.
[37] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[38] M. L. Beau,et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome , 2002, Nature Genetics.
[39] H. Hidaka,et al. Inhibition of Rho‐kinase‐induced myristoylated alanine‐rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H‐1152, a novel and specific Rho‐kinase inhibitor , 2002, Journal of neurochemistry.
[40] Dean Nizetic,et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia , 2001, Nature Genetics.
[41] Nicole Dastugue,et al. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] D. Neuberg,et al. Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. , 2000, Blood.
[43] Thomas D. Y. Chung,et al. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.
[44] Y. Hayashi,et al. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia , 1989, British journal of haematology.
[45] B. Bain,et al. Enhanced reactivity in mixed leukocyte cultures after separation of mononuclear cells on Ficoll-Hypaque. , 1972, Transplantation proceedings.
[46] Mindy I. Davis,et al. A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.
[47] M. Mann,et al. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.